KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Instant Peptides: 72 Kovera certificates.
The lab's record shows 72 certificates printed for Instant Peptides, analysed between 7 Mar 2026 and 21 May 2026, covering 37 products. Median HPLC purity is 99.92%. Kovera graded 66 as a pass and 5 as a fail; 1 carry no verdict.
72
certificates
99.92%
median purity
37
products
5
lab verdict: fail
5
failure rules met
What the record shows
RETRIEVED 2 AUGUST 20265 of the 72 certificates meet at least one of our failure rules. They are shaded in the table below. 34 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
37 AS PRINTEDGLP-3 RT · 7GLP-2 TRZ · 5MOTS-c · 5NAD+ · 5CJC-1295 (No DAC)/Ipamorelin · 4GHK-Cu · 4BPC-157 · 3Retatrutide · 35-Amino-1MQ · 2BPC-157/TB-500 · 2GLP-1 SM · 2Glutathione · 2Melanotan-2 · 2Semaglutide · 2Tesamorelin · 2AOD-9604 · 1ARA-290 · 1CJC-1295 no DAC · 1DSIP · 1Epithalon · 1Glow · 1IGF-1 LR3 · 1Ipamorelin · 1Kisspeptin-10 · 1Klow · 1KPV · 1LL-37 · 1Melanotan-1 · 1Methylene Blue (Capsule) · 1N-Acetyl Selank Amidate · 1N-Acetyl Semax Amidate · 1PT-141 · 1SS-31 · 1TB-500 (Thymosin B4) · 1Tesamorelin/Ipamorelin · 1Thymosin alpha-1 · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 72 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-A2EA93 | NAD+ | 2026-0245-E | 99.699% | 96.4%482.24 of 500 mg | 21 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AAE9E6 | MOTS-c | 2026-0311-B | 99.762% | 112.6%11.26 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8CFB92 | BPC-157 | 2026-0309-B | 98.963% | 112.1%22.42 of 20 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4DCA6B | GLP-2 TRZ | 2026-0230-C | 99.817% | 113.7%11.37 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-2C5937 | Tesamorelin/Ipamorelin | 2026-0315-A | 99.758% | 111.6%17.86 of 16 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-195B15 | GLP-3 RT | 2026-0235-E | 99.133% | 105.9%31.77 of 30 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0940DE | GLP-3 RT | 2026-0234-G | 99.859% | 115.1%17.27 of 15 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6E76EF | NAD+ | 2026-0245-D | 99.809% | 92.7%463.38 of 500 mg | 19 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-DB6AB6 | Tesamorelin | 2026-0299-D | 99.871% | 105.8%10.58 of 10 mg | 18 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F3BFF6 | MOTS-c | 2026-0242-E | 99.927% | 100.9%40.37 of 40 mg | 17 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C0CE4D | GLP-3 RT | 2026-0234-F | 99.828% | 111.5%16.73 of 15 mg | 17 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9C8569 | Glow | 2026-0240-D | 99.742% | 110.3%77.24 of 70 mg | 17 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6BFFF6 | Melanotan-2 | 2026-0274-C | 99.873% | 92.4%9.24 of 10 mg | 17 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BB883A | BPC-157/TB-500 | 2026-0253-C | 99.781% | 110.4%22.08 of 20 mg | 16 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-2D3C78 | Glutathione | 2026-0236-B | 99.853% | 94.8%1421.44 of 1500 mg | 16 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CA5B72 | NAD+ | 2026-0245-C | 99.936% | — | 11 May 2026 | faillab verdict: fail · identity not confirmed | Kovera ↗our verifier → |
| KVR-2026-9197F8 | GLP-3 RT | 2026-0234-E | 99.882% | — | 11 May 2026 | faillab verdict: fail · identity not confirmed | Kovera ↗our verifier → |
| KVR-2026-0815CD | Tesamorelin | 2026-0299-D | 99.933% | — | 11 May 2026 | faillab verdict: fail · identity not confirmed | Kovera ↗our verifier → |
| KVR-2026-8FA2E0 | Melanotan-2 | 2026-0274-B | 99.889% | 70.3%7.03 of 10 mg | 6 May 2026 | faillab verdict: fail · under 90% of label | Kovera ↗our verifier → |
| KVR-2026-D358EB | GHK-Cu | 2026-0308-B | 99.946% | 104.5%52.27 of 50 mg | 29 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B82564 | Epithalon | 2026-0262-B | 99.901% | 130.3%13.03 of 10 mg | 29 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-660E15 | GLP-2 TRZ | 2026-0232-A | 99.844% | 111.0%44.38 of 40 mg | 29 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-550573 | BPC-157/TB-500 | 2026-0253-B | 99.493% | 88.8%35.54 of 40 mg | 29 Apr 2026 | faillab verdict: fail · under 90% of label | Kovera ↗our verifier → |
| KVR-2026-11D370 | GHK-Cu | 2026-0239-B | 99.852% | 107.8%107.79 of 100 mg | 29 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FF0D88 | NAD+ | 2026-0245-B | 99.883% | 106.0%530.12 of 500 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D22147 | Glutathione | 2026-0314-A | 99.941% | 96.3%577.85 of 600 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CFCCDC | TB-500 (Thymosin B4) | 2026-0238-B | 99.929% | 112.1%11.21 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A04CA6 | CJC-1295 (No DAC)/Ipamorelin | 2026-0259-E | 99.852% | 114.0%11.4 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-93B78B | Klow | 2026-0270-C | 99.856% | 106.2%84.96 of 80 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-562AC0 | PT-141 | 2026-0282-A | 99.948% | 108.3%10.83 of 10 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-53DDCD | GLP-3 RT | 2026-0235-D | 99.882% | 110.6%33.18 of 30 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-271AB5 | 5-Amino-1MQ | 2026-0312-A | 99.983% | 108.8%54.39 of 50 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-01FC9F | LL-37 | 2026-0313-A | 99.866% | 115.6%5.78 of 5 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-00FA52 | MOTS-c | 2026-0311-A | 99.898% | 109.6%10.96 of 10 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CEF792 | CJC-1295 (No DAC)/Ipamorelin | 2026-0259-E | 99.797% | 114.8%11.48 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C16F81 | GLP-1 SM | 2026-0287-B | 99.801% | 111.8%33.53 of 30 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-618E7F | Thymosin alpha-1 | 2026-0296-A | 99.857% | 111.4%11.14 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E45BD2 | IGF-1 LR3 | 2026-0241-B | 99.979% | 106.0%1.06 of 1 mg | 6 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CD2C45 | Melanotan-1 | 2026-0273-A | 99.923% | 113.9%11.39 of 10 mg | 6 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B3B10E | Ipamorelin | 2026-0268-A | 99.927% | 118.3%11.83 of 10 mg | 6 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A0706B | 5-Amino-1MQ | 2026-0247-B | 99.924% | 109.6%10.96 of 10 mg | 6 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-22A1DB | KPV | 2026-0243-B | 99.976% | 118.8%11.88 of 10 mg | 6 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-10F9BF | MOTS-c | 2026-0242-D | 99.924% | 107.5%42.98 of 40 mg | 6 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EBED65 | GLP-1 SM | 2026-0286-B | 99.943% | 111.8%11.18 of 10 mg | 5 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-32B5E6 | GLP-2 TRZ | 2026-0233-C | 99.954% | 107.5%64.47 of 60 mg | 5 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-206642 | BPC-157 | 2026-0237-B | 99.923% | 109.3%10.93 of 10 mg | 5 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BFAD27 | GLP-3 RT | 2026-0310-A | 99.951% | 118.6%11.86 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C1CEED | SS-31 | 2026-0292-D | 99.983% | 111.1%11.11 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-687E15 | N-Acetyl Semax Amidate | 2026-0288-B | 99.95% | 118.0%11.8 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-472FC1 | N-Acetyl Selank Amidate | 2026-0285-B | 99.924% | — | 29 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-1919C9 | BPC-157 | 2026-0309-A | 99.968% | 106.2%21.24 of 20 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0AB747 | CJC-1295 no DAC | 2026-0303-B | 99.928% | 106.4%5.32 of 5 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-83BF48 | GHK-Cu | 2026-0308-A | 99.936% | 110.5%55.26 of 50 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-593B80 | CJC-1295 (No DAC)/Ipamorelin | 2026-0259-D | 99.864% | 114.8%11.48 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1E3B4F | GLP-3 RT | 2026-0284-D | 99.949% | 105.9%63.56 of 60 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F7C3EE | ARA-290 | 2026-0307-A | 99.986% | 117.9%11.79 of 10 mg | 25 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5F1D04 | GLP-2 TRZ | 2026-0230-B | 99.924% | 106.1%10.61 of 10 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3823E8 | GLP-2 TRZ | 2026-0231-B | 99.943% | 107.7%21.53 of 20 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-7D8B3C | AOD-9604 | 2026-0250-A | 99.968% | 109.6%5.48 of 5 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B160DE | MOTS-c | 2026-0242-C | 99.922% | 117.9%47.15 of 40 mg | 21 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0D8C76 | Retatrutide | 2026/0234-D | 99.944% | 113.9%17.08 of 15 mg | 21 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-80FC11 | Methylene Blue (Capsule) | 2026-MBLUE-01 | 99.974% | 109.6%21.92 of 20 mg | 20 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E32D51 | Retatrutide | 2026-0284-C | 99.934% | 106.7%64.04 of 60 mg | 18 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BA21A1 | Retatrutide | 2026-0235-C | 99.972% | 108.4%32.51 of 30 mg | 18 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-839B02 | DSIP | 2026-0261-A | 99.967% | 114.8%5.74 of 5 mg | 18 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0CB221 | CJC-1295 (No DAC)/Ipamorelin | 2026-0259-C | 99.777% | 110.2%11.02 of 10 mg | 13 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C77872 | Semaglutide | 2026-0286-A | 99.969% | 113.8%11.38 of 10 mg | 9 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-934E20 | Tirzepatide | 2026-0233-B | 99.924% | 107.6%64.54 of 60 mg | 9 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-67A397 | Semaglutide | 2026-0287-A | 99.977% | 108.9%32.67 of 30 mg | 9 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5DBED6 | GHK-Cu | 2026-0239-A | 99.974% | 109.6%109.63 of 100 mg | 9 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-25A92D | NAD+ | 2026-0245-A | 99.928% | 110.5%552.28 of 500 mg | 9 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5D72AB | Kisspeptin-10 | 2026-0269-A | 99.946% | 110.9%11.09 of 10 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |